Advertisement

BPH/LUTS

Minimally invasive connective water vapor energy method for benign prostatic hyperplasia.

Dec 11, 2023

The Rezūm system has emerged as a promising treatment option for benign prostatic hyperplasia (BPH) by employing endoscopic removal of prostate tissue. This meta-analysis aimed to evaluate the benefi...

Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.

Nov 13, 2023

Prostatic carcinoma (PCA) is a rare but severe condition in dogs that is similar to the androgen-independent form of PCA in men. In contrast to humans, PCA is difficult to diagnose in dogs as reliable...

The relationship between depression and benign prostatic hyperplasia in middle-aged and elderly men in India: a large-scale population study.

Nov 06, 2023

There have been few investigations on the association between depression and benign prostatic hyperplasia (BPH). This study aims to explore the correlation between depression and BPH among middle-aged...

iPCa-Net: A CNN-based framework for predicting incidental prostate cancer using multiparametric MRI.

Nov 06, 2023

Incidental prostate cancer (iPCa) is an early stage of clinically significant prostate cancer (csPCa) and is typically asymptomatic, making it difficult to detect in clinical practice. The objective o...

Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.

Oct 30, 2023

The management of benign prostatic obstruction (BPO) should involve a treatment algorithm that takes into account prostate size, and patient's symptoms and preference with the aim of helping with urin...

Association of serum uric acid levels with benign prostatic hyperplasia in US men: results from NHANES 2005-2008.

Oct 30, 2023

The relationship between uric acid (UA) and benign prostatic hyperplasia (BPH) is controversial and has rarely been studied in American populations.Data from two cycles of the National Health and Nutr...

STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.

Oct 23, 2023

Benign prostatic hyperplasia (BPH) is a quite common chronic disease plagued elderly men and its etiology remains unclear. It was reported that the six-transmembrane epithelial antigen of prostate 4 (...

Possible therapeutic role of zinc oxide nanoparticles versus vanillic acid in testosterone-induced benign prostatic hyperplasia in adult albino rat: A histological, immunohistochemical and biochemical study.

Oct 23, 2023

The search for alternative therapies for treatment of Benign prostatic hyperplasia (BPH) has been increasingly studied to avoid the common adverse effects of the usual regimens. Therefore, this study ...

Comparison of IPSS score and voiding parameters in men presenting with LUTS.

Oct 16, 2023

This study compares subjective lower urinary tract symptoms (LUTS) to objective voiding parameters measured during the UroCuff Test, a non-invasive pressure flow study (PFS), in men presenting with LU...

Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract symptoms: a matching-adjusted indirect comparison.

Oct 16, 2023

To evaluate the safety and efficacy of the temporarily implanted nitinol device (iTind) versus prostatic urethral lift (PUL) for minimally invasive surgical treatment of lower urinary tract symptoms s...

Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence.

Oct 09, 2023

Finasteride and minoxidil are medicaments commonly prescribed for treating benign prostatic hyperplasia (BPA), hypertension, and/or androgenetic alopecia (AGA). The mechanism of action of finasteride ...

TESTOSTERONE AND SERUM ZINC LEVELS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA.

Oct 09, 2023

Benign prostatic hyperplasia (BPH) is a common benign tumour of the prostate that becomes more common as men age. The purpose of this study is to investigate the relationships between serum zinc and t...

Emerging Technologies for the Surgical Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction. A Systematic Review.

Sep 25, 2023

Surgical management of lower urinary tract symptoms (LUTS)/benign prostatic obstruction (BPO) aims at ablating prostate adenoma by resection, enucleation, or vaporisation. Apart from established ablat...

Multi-scale statistical deformation based co-registration of prostate MRI and post-surgical whole mount histopathology.

Sep 25, 2023

Accurate delineations of regions of interest (ROIs) on multi-parametric magnetic resonance imaging (mpMRI) are crucial for development of automated, machine learning-based prostate cancer (PCa) detect...

Standardized technique for ejaculation preservation during prostatic endoscopic ablative surgery.

Sep 18, 2023

Ejaculatory dysfunction is the most common side effect of benign prostatic hyperplasia surgery. Modified techniques have emerged with the aim of preserving antegrade ejaculation without compromising o...

Is Holmium Laser Enucleation of the Prostate Truly Size-Independent? A Critical Evaluation at the Extreme Ends of the Spectrum.

Sep 18, 2023

To assess the outcomes of Holmium Laser Enucleation of the Prostate (HoLEP) at the extremes of the size spectrum, comparing whether the results are consistent for very large and small prostates.A retr...

The Composition of Fatty Acids in Bee Pollen, Royal Jelly, Buckthorn Oil and Their Mixtures with Pollen Preserved for Storage.

Sep 11, 2023

Honey produced by contains minor components present in the nectar collected from plants. Various studies of honey components and all other bee products can be informative in assessing their quality. ...

Is day-case surgery feasible for laser endoscopic enucleation of the prostate? A systematic review.

Sep 11, 2023

Laser endoscopic enucleation of the prostate (EEP) for benign prostatic obstruction has become increasingly prevalent worldwide. Considering the medical cost-savings and concomitantly fewer nosocomial...

Inhibition of integrin receptors reduces extracellular matrix levels, ameliorating benign prostate hyperplasia.

Sep 04, 2023

Although a high prevalence of benign prostate hyperplasia (BPH) has been documented, the risk factors are poorly understood. Metabolic syndrome increases the risk of BPH. Succinylation, a type of post...

A scoping review of risk factors for urinary incontinence in older men.

Sep 04, 2023

Most epidemiological studies have not systematically identified or categorized risk factors for urinary incontinence (UI) in older men, despite a higher prevalence than in younger men. Considering the...

SUBSPECIALTIES

Advertisement